| Product Code: ETC9967288 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Haematology Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Haematology Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Haematology Market - Industry Life Cycle |
3.4 United States (US) Haematology Market - Porter's Five Forces |
3.5 United States (US) Haematology Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 United States (US) Haematology Market Revenues & Volume Share, By Reagent, 2021 & 2031F |
3.7 United States (US) Haematology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 United States (US) Haematology Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United States (US) Haematology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of blood disorders and diseases in the US |
4.2.2 Technological advancements in haematology diagnostics and treatments |
4.2.3 Growing demand for personalized medicine and targeted therapies in haematology |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for haematology products and services |
4.3.2 High costs associated with haematology treatments and procedures |
4.3.3 Limited access to specialized haematology healthcare services in certain regions of the US |
5 United States (US) Haematology Market Trends |
6 United States (US) Haematology Market, By Types |
6.1 United States (US) Haematology Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Haematology Market Revenues & Volume, By Product, 2021- 2031F |
6.1.3 United States (US) Haematology Market Revenues & Volume, By Haematology Analyzers, 2021- 2031F |
6.1.4 United States (US) Haematology Market Revenues & Volume, By Flow Cytometers, 2021- 2031F |
6.1.5 United States (US) Haematology Market Revenues & Volume, By Coagulation Analyzers, 2021- 2031F |
6.1.6 United States (US) Haematology Market Revenues & Volume, By Slide Stainers, 2021- 2031F |
6.1.7 United States (US) Haematology Market Revenues & Volume, By Centrifuges, 2021- 2031F |
6.1.8 United States (US) Haematology Market Revenues & Volume, By Hemoglobinometers, 2021- 2031F |
6.2 United States (US) Haematology Market, By Reagent |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Haematology Market Revenues & Volume, By Coagulation Reagents, 2021- 2031F |
6.2.3 United States (US) Haematology Market Revenues & Volume, By Flow Cytometry Reagents, 2021- 2031F |
6.2.4 United States (US) Haematology Market Revenues & Volume, By Immuno-Haematology Reagents, 2021- 2031F |
6.2.5 United States (US) Haematology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Haematology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Haematology Market Revenues & Volume, By Drug Testing, 2021- 2031F |
6.3.3 United States (US) Haematology Market Revenues & Volume, By Auto Immune Disease, 2021- 2031F |
6.3.4 United States (US) Haematology Market Revenues & Volume, By Cancer, 2021- 2031F |
6.3.5 United States (US) Haematology Market Revenues & Volume, By Diabetes Mellitus, 2021- 2031F |
6.3.6 United States (US) Haematology Market Revenues & Volume, By Infectious Disease, 2021- 2031F |
6.3.7 United States (US) Haematology Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Haematology Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Haematology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Haematology Market Revenues & Volume, By Clinical Testing Institutes, 2021- 2031F |
6.4.4 United States (US) Haematology Market Revenues & Volume, By Patient Self-Testing, 2021- 2031F |
6.4.5 United States (US) Haematology Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Haematology Market Import-Export Trade Statistics |
7.1 United States (US) Haematology Market Export to Major Countries |
7.2 United States (US) Haematology Market Imports from Major Countries |
8 United States (US) Haematology Market Key Performance Indicators |
8.1 Adoption rate of new haematology diagnostic technologies in the US |
8.2 Percentage of haematology patients opting for personalized medicine approaches |
8.3 Number of clinical trials and research studies focused on haematology treatments in the US. |
9 United States (US) Haematology Market - Opportunity Assessment |
9.1 United States (US) Haematology Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 United States (US) Haematology Market Opportunity Assessment, By Reagent, 2021 & 2031F |
9.3 United States (US) Haematology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 United States (US) Haematology Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United States (US) Haematology Market - Competitive Landscape |
10.1 United States (US) Haematology Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Haematology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here